Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Saud A Sadiq

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Stem Cells and Development|February 9, 2011
Mesenchymal stem cells enhance the engraftment and myelinating ability of allogeneic oligodendrocyte progenitors in dysmyelinated miceMassimiliano Cristofanilli, Violaine K Harris, Aaron Zigelbaum, et al.
Ebiomedicine|February 17, 2018
Phase I Trial of Intrathecal Mesenchymal Stem Cell-derived Neural Progenitors in Progressive Multiple SclerosisViolaine K Harris, James Stark, Tamara Vyshkina, et al.
Frontiers in Molecular Neuroscience|October 19, 2013
Effects of intraventricular methotrexate administration on Cuprizone-induced demyelination in miceAndre M Mueller, Adam Nassery, Hana Conlon, et al.
Frontiers in Immunology|August 22, 2022
Strong T-cell activation in response to COVID-19 vaccination in multiple sclerosis patients receiving B-cell depleting therapiesRoberto Alfonso-Dunn, Jerry Lin, Vanessa Kirschner, et al.
Archives of Physical Medicine and Rehabilitation|June 6, 2002
Abrupt withdrawal from intrathecal baclofen: recognition and management of a potentially life-threatening syndromeRobert J Coffey, Terence S Edgar, Gerard E Francisco, et al.
Frontiers in Immunology|July 14, 2023
Humoral and cellular responses to repeated COVID-19 exposure in multiple sclerosis patients receiving B-cell depleting therapies: a single-center, one-year, prospective studyRoberto Alfonso-Dunn, Jerry Lin, Joyce Lei, et al.
Stem Cell Research & Therapy|May 24, 2024
Efficacy of intrathecal mesenchymal stem cell-neural progenitor therapy in progressive MS: results from a phase II, randomized, placebo-controlled clinical trialViolaine K Harris, James Stark, Armistead Williams, et al.
Brain Communications|August 31, 2022
Apolipoprotein B-100-mediated motor neuron degeneration in sporadic amyotrophic lateral sclerosisJamie K Wong, Anna K Roselle, Taylor M Shue, et al.
Brain : a Journal of Neurology|February 2, 2023
Cerebrospinal fluid immunoglobulins in primary progressive multiple sclerosis are pathogenicJamie K Wong, Jerry Lin, Nathan J Kung, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 24, 2025
Central TYK2 inhibition identifies TYK2 as a key neuroimmune modulatorTyler P Molitor, Genki Hayashi, Mei-Yao Lin, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Stem Cells and Development|February 9, 2011
Mesenchymal stem cells enhance the engraftment and myelinating ability of allogeneic oligodendrocyte progenitors in dysmyelinated miceMassimiliano Cristofanilli, Violaine K Harris, Aaron Zigelbaum, et al.
Ebiomedicine|February 17, 2018
Phase I Trial of Intrathecal Mesenchymal Stem Cell-derived Neural Progenitors in Progressive Multiple SclerosisViolaine K Harris, James Stark, Tamara Vyshkina, et al.
Frontiers in Molecular Neuroscience|October 19, 2013
Effects of intraventricular methotrexate administration on Cuprizone-induced demyelination in miceAndre M Mueller, Adam Nassery, Hana Conlon, et al.
Frontiers in Immunology|August 22, 2022
Strong T-cell activation in response to COVID-19 vaccination in multiple sclerosis patients receiving B-cell depleting therapiesRoberto Alfonso-Dunn, Jerry Lin, Vanessa Kirschner, et al.
Archives of Physical Medicine and Rehabilitation|June 6, 2002
Abrupt withdrawal from intrathecal baclofen: recognition and management of a potentially life-threatening syndromeRobert J Coffey, Terence S Edgar, Gerard E Francisco, et al.
Frontiers in Immunology|July 14, 2023
Humoral and cellular responses to repeated COVID-19 exposure in multiple sclerosis patients receiving B-cell depleting therapies: a single-center, one-year, prospective studyRoberto Alfonso-Dunn, Jerry Lin, Joyce Lei, et al.
Stem Cell Research & Therapy|May 24, 2024
Efficacy of intrathecal mesenchymal stem cell-neural progenitor therapy in progressive MS: results from a phase II, randomized, placebo-controlled clinical trialViolaine K Harris, James Stark, Armistead Williams, et al.
Brain Communications|August 31, 2022
Apolipoprotein B-100-mediated motor neuron degeneration in sporadic amyotrophic lateral sclerosisJamie K Wong, Anna K Roselle, Taylor M Shue, et al.
Brain : a Journal of Neurology|February 2, 2023
Cerebrospinal fluid immunoglobulins in primary progressive multiple sclerosis are pathogenicJamie K Wong, Jerry Lin, Nathan J Kung, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 24, 2025
Central TYK2 inhibition identifies TYK2 as a key neuroimmune modulatorTyler P Molitor, Genki Hayashi, Mei-Yao Lin, et al.
Pageof 4